Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma

S. Lingala, Y. Y. Cui, X. Chen, B. H. Ruebner, X. F. Qian, Mark A Zern, J. Wu

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Background: Cancer stem cells (CSCs) are thought to be a critical subpopulation in tumor development, progression, metastasis and recurrence, and the identification of these cells is an initial step in understanding their role in oncogenesis and in seeking valuable markers for diagnosis or development of targeting therapeutics. Aims: To identify CSCs in hepatocellular carcinoma (HCC) specimens and define their tissue specificity. Methods: Immunohistochemical staining of CSC markers: CD44, CD90, CD133 and aldehyde dehydrogenase (ALDH) was performed in 25 HCC specimens, 4 hepatoblastomas, 8 peri-malignant tissues, and 19 cases of viral hepatitis. Results: The positivity of CD44 staining in HCC specimens was significantly lower than in viral hepatitis specimens. The positive rate of CD133 in HCC was similar to viral hepatitis specimens. CD133+ cells were largely localized to ALDH-positive cells in HCC as revealed by confocal microscopy. In contrast, the co-expression of both markers was visualized within vessels or in the portal areas in viral hepatitis. Moreover, among 7 liver specimens adjacent to HCC tissue, 3-6 samples were positive for CD44, CD90, CD133 and ALDH, especially in dysplastic cells. One of 4 hepatoblastoma cases was positive for all these markers; whereas, the other three specimens were negative for all these CSC markers. Conclusions: In HCC and dysplastic tissues, clusters of CD133+/ALDHhigh cells were identified. The use of cancer stem cell markers to screen tissues with chronic liver diseases provides limited guidance in the identification of malignant cells.

Original languageEnglish (US)
Pages (from-to)27-35
Number of pages9
JournalExperimental and Molecular Pathology
Volume89
Issue number1
DOIs
StatePublished - Aug 2010

Fingerprint

Neoplastic Stem Cells
Stem cells
Hepatocellular Carcinoma
Aldehyde Dehydrogenase
Tissue
Staining and Labeling
Hepatitis
Hepatoblastoma
Liver
Confocal microscopy
Organ Specificity
Tumors
Cells
Confocal Microscopy
Liver Diseases
Carcinogenesis
Chronic Disease
Neoplasm Metastasis
Recurrence
Neoplasms

Keywords

  • Aldehyde dehydrogenase
  • Cancer stem cells
  • CD133
  • CD44
  • CD90
  • Hepatocellular carcinoma and hepatoblastoma

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Pathology and Forensic Medicine

Cite this

Lingala, S., Cui, Y. Y., Chen, X., Ruebner, B. H., Qian, X. F., Zern, M. A., & Wu, J. (2010). Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Experimental and Molecular Pathology, 89(1), 27-35. https://doi.org/10.1016/j.yexmp.2010.05.005

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. / Lingala, S.; Cui, Y. Y.; Chen, X.; Ruebner, B. H.; Qian, X. F.; Zern, Mark A; Wu, J.

In: Experimental and Molecular Pathology, Vol. 89, No. 1, 08.2010, p. 27-35.

Research output: Contribution to journalArticle

Lingala, S, Cui, YY, Chen, X, Ruebner, BH, Qian, XF, Zern, MA & Wu, J 2010, 'Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma', Experimental and Molecular Pathology, vol. 89, no. 1, pp. 27-35. https://doi.org/10.1016/j.yexmp.2010.05.005
Lingala, S. ; Cui, Y. Y. ; Chen, X. ; Ruebner, B. H. ; Qian, X. F. ; Zern, Mark A ; Wu, J. / Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. In: Experimental and Molecular Pathology. 2010 ; Vol. 89, No. 1. pp. 27-35.
@article{1c523e1160c54ecfba706520ae74c249,
title = "Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma",
abstract = "Background: Cancer stem cells (CSCs) are thought to be a critical subpopulation in tumor development, progression, metastasis and recurrence, and the identification of these cells is an initial step in understanding their role in oncogenesis and in seeking valuable markers for diagnosis or development of targeting therapeutics. Aims: To identify CSCs in hepatocellular carcinoma (HCC) specimens and define their tissue specificity. Methods: Immunohistochemical staining of CSC markers: CD44, CD90, CD133 and aldehyde dehydrogenase (ALDH) was performed in 25 HCC specimens, 4 hepatoblastomas, 8 peri-malignant tissues, and 19 cases of viral hepatitis. Results: The positivity of CD44 staining in HCC specimens was significantly lower than in viral hepatitis specimens. The positive rate of CD133 in HCC was similar to viral hepatitis specimens. CD133+ cells were largely localized to ALDH-positive cells in HCC as revealed by confocal microscopy. In contrast, the co-expression of both markers was visualized within vessels or in the portal areas in viral hepatitis. Moreover, among 7 liver specimens adjacent to HCC tissue, 3-6 samples were positive for CD44, CD90, CD133 and ALDH, especially in dysplastic cells. One of 4 hepatoblastoma cases was positive for all these markers; whereas, the other three specimens were negative for all these CSC markers. Conclusions: In HCC and dysplastic tissues, clusters of CD133+/ALDHhigh cells were identified. The use of cancer stem cell markers to screen tissues with chronic liver diseases provides limited guidance in the identification of malignant cells.",
keywords = "Aldehyde dehydrogenase, Cancer stem cells, CD133, CD44, CD90, Hepatocellular carcinoma and hepatoblastoma",
author = "S. Lingala and Cui, {Y. Y.} and X. Chen and Ruebner, {B. H.} and Qian, {X. F.} and Zern, {Mark A} and J. Wu",
year = "2010",
month = "8",
doi = "10.1016/j.yexmp.2010.05.005",
language = "English (US)",
volume = "89",
pages = "27--35",
journal = "Experimental and Molecular Pathology",
issn = "0014-4800",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma

AU - Lingala, S.

AU - Cui, Y. Y.

AU - Chen, X.

AU - Ruebner, B. H.

AU - Qian, X. F.

AU - Zern, Mark A

AU - Wu, J.

PY - 2010/8

Y1 - 2010/8

N2 - Background: Cancer stem cells (CSCs) are thought to be a critical subpopulation in tumor development, progression, metastasis and recurrence, and the identification of these cells is an initial step in understanding their role in oncogenesis and in seeking valuable markers for diagnosis or development of targeting therapeutics. Aims: To identify CSCs in hepatocellular carcinoma (HCC) specimens and define their tissue specificity. Methods: Immunohistochemical staining of CSC markers: CD44, CD90, CD133 and aldehyde dehydrogenase (ALDH) was performed in 25 HCC specimens, 4 hepatoblastomas, 8 peri-malignant tissues, and 19 cases of viral hepatitis. Results: The positivity of CD44 staining in HCC specimens was significantly lower than in viral hepatitis specimens. The positive rate of CD133 in HCC was similar to viral hepatitis specimens. CD133+ cells were largely localized to ALDH-positive cells in HCC as revealed by confocal microscopy. In contrast, the co-expression of both markers was visualized within vessels or in the portal areas in viral hepatitis. Moreover, among 7 liver specimens adjacent to HCC tissue, 3-6 samples were positive for CD44, CD90, CD133 and ALDH, especially in dysplastic cells. One of 4 hepatoblastoma cases was positive for all these markers; whereas, the other three specimens were negative for all these CSC markers. Conclusions: In HCC and dysplastic tissues, clusters of CD133+/ALDHhigh cells were identified. The use of cancer stem cell markers to screen tissues with chronic liver diseases provides limited guidance in the identification of malignant cells.

AB - Background: Cancer stem cells (CSCs) are thought to be a critical subpopulation in tumor development, progression, metastasis and recurrence, and the identification of these cells is an initial step in understanding their role in oncogenesis and in seeking valuable markers for diagnosis or development of targeting therapeutics. Aims: To identify CSCs in hepatocellular carcinoma (HCC) specimens and define their tissue specificity. Methods: Immunohistochemical staining of CSC markers: CD44, CD90, CD133 and aldehyde dehydrogenase (ALDH) was performed in 25 HCC specimens, 4 hepatoblastomas, 8 peri-malignant tissues, and 19 cases of viral hepatitis. Results: The positivity of CD44 staining in HCC specimens was significantly lower than in viral hepatitis specimens. The positive rate of CD133 in HCC was similar to viral hepatitis specimens. CD133+ cells were largely localized to ALDH-positive cells in HCC as revealed by confocal microscopy. In contrast, the co-expression of both markers was visualized within vessels or in the portal areas in viral hepatitis. Moreover, among 7 liver specimens adjacent to HCC tissue, 3-6 samples were positive for CD44, CD90, CD133 and ALDH, especially in dysplastic cells. One of 4 hepatoblastoma cases was positive for all these markers; whereas, the other three specimens were negative for all these CSC markers. Conclusions: In HCC and dysplastic tissues, clusters of CD133+/ALDHhigh cells were identified. The use of cancer stem cell markers to screen tissues with chronic liver diseases provides limited guidance in the identification of malignant cells.

KW - Aldehyde dehydrogenase

KW - Cancer stem cells

KW - CD133

KW - CD44

KW - CD90

KW - Hepatocellular carcinoma and hepatoblastoma

UR - http://www.scopus.com/inward/record.url?scp=77954030910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954030910&partnerID=8YFLogxK

U2 - 10.1016/j.yexmp.2010.05.005

DO - 10.1016/j.yexmp.2010.05.005

M3 - Article

C2 - 20511115

AN - SCOPUS:77954030910

VL - 89

SP - 27

EP - 35

JO - Experimental and Molecular Pathology

JF - Experimental and Molecular Pathology

SN - 0014-4800

IS - 1

ER -